Form 6-K GLAXOSMITHKLINE PLC For: Oct 03
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For
period ending 03 October 2016
GlaxoSmithKline plc
(Name
of registrant)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or
will
file annual reports under cover Form 20-F or Form 40-F
Form
20-F x Form 40-F
--
Indicate
by check mark whether the registrant by furnishing the
information
contained in this Form is also thereby furnishing the
information
to the Commission pursuant to Rule 12g3-2(b) under the
Securities
Exchange Act of 1934.
Yes
No x
GlaxoSmithKline plc
Total Voting Rights and Capital
In
conformity with Disclosure and Transparency Rule 5.6.1R,
GlaxoSmithKline plc (the 'Company') hereby notifies the market of
the following:
The
Company's issued share capital as at 30 September 2016 consisted of
5,367,261,326 Ordinary Shares of 25p each, of which 491,505,950 Ordinary Shares were held in
Treasury.
Therefore,
the total number of voting rights in the Company is 4,875,755,376.
This figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
Company under the Financial Conduct Authority's Disclosure and
Transparency Rules.
V A Whyte
Company Secretary
3
October 2016
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
GlaxoSmithKline plc
(Registrant)
Date: October
03, 2016
By: VICTORIA
WHYTE
----------------------
Victoria Whyte
Authorised
Signatory for and on
behalf
of GlaxoSmithKline plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Callan's 2024 Defined Contribution Trends Survey: Governance and Fees Top of Mind for DC Plan Sponsors
- Union Pacific Reports First Quarter 2024 Results
- Predictmedix AI Expands Reach and Impact in Healthcare Transformation Efforts
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!